focus -WSS

focus

author：comprehensive 2025-08-23 06:50:41 - browse：36

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Why palliative psychiatry is worth discussing

WSS

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

STAT readers on older presidents, polypills, Medicare, and more

Calls for Trump's election interference trial to be televised part of long debate

Dario to buy mental health app maker Twill in cash and stock deal

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

focus

focus

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Guidelines to prevent youth baseball injuries need more muscle

New documents shed light on MD Anderson Cancer Institute feud

State Dept. review finds Biden bears some blame for Afghanistan failures

The Harvard botanist who searched for psychedelics in the Amazon

State Dept. review finds Biden bears some blame for Afghanistan failures

With competition flaring, obesity drug hits goal in liver disease study

Virginia high school admissions case could be legal follow

Dario to buy mental health app maker Twill in cash and stock deal

focus

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Why palliative psychiatry is worth discussing

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Russian court extends detention of American musician

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

leisure time

focus

hotspot

hotspot